Heterogeneity at the CETP gene locus: Influence on plasma CETP concentrations and HDL cholesterol levels

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 3, 1997, Pages 560-568

  Kuivenhoven, Jan Albert ^a,e   De Knijff, Peter ^b   Boer, Jolanda M A ^c   Smalheer, Harold A ^a   Botma, Gert Jan ^a   Seidell, Jaap C ^c   Kastelein, John J P ^a   Haydn Pritchard, P ^d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

cholesteryl ester transfer protein; coronary artery disease; haplotyping; high density lipoprotein; restriction fragment length polymorphism

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; HYPOLIPOPROTEINEMIA; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0030934834     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.3.560     Document Type: Article

References (15)

1. Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromso Heart Study: high-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet. 1977;1:965-968.
2. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Heart Study. Am J Med. 1977;62:707-714.
3. Assmann G, Schulte H, Oberwitter W, Hause WH. New aspects in the prediction of coronary artery disease: the Prospective Cardiovascular Munster Study. In: Fidge NH, Nestel PJ, eds. Atherosclerosis VII. Amsterdam, Netherlands: Elsevier Science Publishers; 1986:19-24.
4. Glomset J. Plasma lecithin:cholesterol acyltransferase. In: Nelson G, ed. Blood Lipids and Lipoproteins. New York, NY: John Wiley & Sons Inc; 1972;14:745-787.
5. Bruce C, Tall AR. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol. 1995;6:306-311.
6. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-228.
7. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res. 1993;34:1255-1274.
8. Tollefson JH, Liu A, Albers JJ. Regulation of plasma lipid transfer by the plasma high density lipoproteins. Am J Physiol. 1988;225:894-902.
9. Freeman DJ, Packard CJ, Shepherd J, Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci. 1990;79:575-581.
10. Hannuksela ML, Liinamaa MJ, Kesäniemi YA, Savolainen MJ. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis. 1994;110:35-44.
11. Savolainen MJ, Hannuksela ML, Seppänen S, Kervinen K, Kesäniemi YA. Increased high-density lipoprotein cholesterol concentration in alcoholics is related to cholesteryl ester transfer protein activity. Eur J Clin Invest. 1990;20:593.
12. Tato F, Vega GL, Grundy SM. Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterol concentrations. Arterioscler Thromb Vasc Biol. 1995;15:446-451.
13. Pattnaik NM, Mones A, Hughes L, Zilversmit DB. Cholesteryl ester exchange protein in human plasma: isolation and characterisation. Biochim Biophys Acta. 1978;530:428-438.
14. Groener JEM, Van Rozen AJ, Erkelens DW. Cholesteryl ester transfer activity: localisation and role in distribution of cholesteryl ester among lipoproteins in man. Atherosclerosis. 1984;50:261-271.
15. Bhatnagar D, Durrington PN, Channon KM, Prais H, Mackness MI. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis. 1993;98:25-32.